Suppr超能文献

相似文献

1
Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.
Gastroenterology. 2016 Jun;150(7):1545-1557.e2. doi: 10.1053/j.gastro.2016.03.040. Epub 2016 Apr 9.
2
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.
Biophys J. 2016 May 10;110(9):2106-19. doi: 10.1016/j.bpj.2016.03.040.
3
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
Br J Cancer. 2013 Jan 15;108(1):1-8. doi: 10.1038/bjc.2012.569. Epub 2013 Jan 8.
4
Generation of an in vitro 3D PDAC stroma rich spheroid model.
Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2.
5
Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
Biochim Biophys Acta. 2012 Aug;1826(1):170-8. doi: 10.1016/j.bbcan.2012.04.002. Epub 2012 Apr 13.
6
Stromal biology and therapy in pancreatic cancer: a changing paradigm.
Gut. 2015 Sep;64(9):1476-84. doi: 10.1136/gutjnl-2015-309304. Epub 2015 May 20.
8
Pancreatic cancer: Stroma and its current and emerging targeted therapies.
Cancer Lett. 2017 Apr 10;391:38-49. doi: 10.1016/j.canlet.2016.12.035. Epub 2017 Jan 14.

引用本文的文献

2
Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024.
Front Pharmacol. 2025 Apr 25;16:1564561. doi: 10.3389/fphar.2025.1564561. eCollection 2025.
4
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.
Int J Nanomedicine. 2025 Mar 17;20:3379-3406. doi: 10.2147/IJN.S504503. eCollection 2025.
5
Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer.
Front Genet. 2025 Feb 18;16:1476092. doi: 10.3389/fgene.2025.1476092. eCollection 2025.
7
Dual rectification of metabolism abnormality in pancreatic cancer by a programmed nanomedicine.
Nat Commun. 2024 Dec 3;15(1):10526. doi: 10.1038/s41467-024-54963-y.
9
Identifying metabolic limitations in the tumor microenvironment.
Sci Adv. 2024 Oct 4;10(40):eadq7305. doi: 10.1126/sciadv.adq7305. Epub 2024 Oct 2.
10
Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma.
J Exp Clin Cancer Res. 2024 Sep 30;43(1):271. doi: 10.1186/s13046-024-03192-8.

本文引用的文献

1
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.
Clin Cancer Res. 2016 Jun 15;22(12):2848-54. doi: 10.1158/1078-0432.CCR-15-2010. Epub 2016 Jan 26.
5
Stromal reengineering to treat pancreas cancer.
Carcinogenesis. 2014 Jul;35(7):1451-60. doi: 10.1093/carcin/bgu115. Epub 2014 Jun 7.
7
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Cancer Cell. 2014 Jun 16;25(6):735-47. doi: 10.1016/j.ccr.2014.04.021. Epub 2014 May 22.
8
Influence of water content and drying on the physical structure of native hyaluronan.
Carbohydr Polym. 2013 Jun 5;95(1):515-21. doi: 10.1016/j.carbpol.2013.03.031. Epub 2013 Mar 16.
9
Genetically engineered mouse models of pancreatic adenocarcinoma.
Mol Oncol. 2013 Apr;7(2):232-47. doi: 10.1016/j.molonc.2013.02.002. Epub 2013 Feb 11.
10
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
Br J Cancer. 2013 Jan 15;108(1):1-8. doi: 10.1038/bjc.2012.569. Epub 2013 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验